Business Description
Jiangsu Yahong Meditech Co Ltd
ISIN : CNE100005XW0
Share Class Description:
SHSE:688176: Class ACompare
Compare
Traded in other countries / regions
688176.China IPO Date
2022-01-07Description
Jiangsu Yahong Meditech Co Ltd is a pharmaceutical company integrating research and development, production and commercialization in the field of focused treatment, providing the integration of diagnosis and treatment for Chinese and global patients Solutions.
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 13.37 | |||||
Equity-to-Asset | 0.9 | |||||
Debt-to-Equity | 0.07 | |||||
Debt-to-EBITDA | -0.4 | |||||
Piotroski F-Score | 1/9 | |||||
Altman Z-Score | 6.7 | |||||
Beneish M-Score | 844.32 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -5.7 | |||||
3-Year EPS without NRI Growth Rate | -12 | |||||
3-Year FCF Growth Rate | -39.8 | |||||
3-Year Book Growth Rate | 33.7 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 46.32 | |||||
9-Day RSI | 45.52 | |||||
14-Day RSI | 43.86 | |||||
6-1 Month Momentum % | -44.79 | |||||
12-1 Month Momentum % | -52.65 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 11.35 | |||||
Quick Ratio | 11.34 | |||||
Cash Ratio | 11.12 | |||||
Days Inventory | 97.73 | |||||
Days Sales Outstanding | 55.96 | |||||
Days Payable | 2600.44 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.4 | |||||
Shareholder Yield % | -2.86 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 78.97 | |||||
Operating Margin % | -1290.75 | |||||
Net Margin % | -1104.72 | |||||
FCF Margin % | -1441.66 | |||||
ROE % | -16.8 | |||||
ROA % | -15.69 | |||||
ROIC % | -171.71 | |||||
ROC (Joel Greenblatt) % | -468.46 | |||||
ROCE % | -16.44 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 82.06 | |||||
PB Ratio | 1.28 | |||||
Price-to-Tangible-Book | 1.32 | |||||
EV-to-EBIT | -2.06 | |||||
EV-to-EBITDA | -2.06 | |||||
EV-to-Revenue | 22.68 | |||||
EV-to-FCF | -1.57 | |||||
Price-to-Net-Current-Asset-Value | 1.44 | |||||
Price-to-Net-Cash | 1.48 | |||||
Earnings Yield (Greenblatt) % | -48.54 | |||||
FCF Yield % | -18.61 |